Related Experiment Video
Updated: Aug 16, 2026
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
Blood lead screening
Arthur N Feinberg1, C Kim Cummings
1Department of Pediatrics, Michigan State University College of Human Medicine, Kalamazoo Center for Medical Studies, Kalamazoo College, MI 49008, USA.
Insights
Lead toxicity testing in Medicaid children is significantly underutilized, with physician and patient factors posing major barriers. Improving screening protocols is crucial for public health and policy changes.
Area of Science:
- Environmental Health
- Pediatrics
- Public Health Policy
Background:
- Lead toxicity is a significant public health concern, particularly in young children.
- Universal blood lead level testing is mandated for Medicaid patients aged 12-36 months by the Centers for Medicare and Medicaid Services.
- Understanding barriers to testing is essential for effective lead poisoning prevention strategies.
Purpose of the Study:
- To evaluate local procedures and identify barriers to blood lead level testing among Medicaid patients.
- To assess the gap between mandated universal testing and actual testing rates.
- To inform public policy for lead abatement and prevention.
Main Methods:
- Retrospective chart review of 675 Medicaid patients aged 12-36 months across 7 practices in Kalamazoo, Michigan.
- Analysis of factors contributing to the absence of blood lead level test results.
- Development and testing of a model for patient and physician barriers to testing.
Main Results:
- Only 27.6% of patients had documented blood lead levels, far below the mandated universal testing rate.
- Physicians overestimated testing rates, even accounting for patient non-compliance.
- Identified barriers included physician failure (37.0%), patient failure (20.0%), and combined failures (10.6%).
Conclusions:
- Significant deficiencies exist in current lead screening procedures for Medicaid children.
- Standardization and unification of screening guidelines are urgently needed.
- Further research, including qualitative methods, is required to understand and address physician and patient barriers to blood lead testing.
Abstract:
To evaluate local procedures for and barriers to testing Medicaid patients for lead toxicity, a retrospective review of 675 charts of Medicaid patients' age 12 to 36 months form the 7 practices who serve the vast majority of Medicaid children in Kalamazoo, Michigan was undertaken. We identified and tested a model for barriers to patients and physicians obtaining blood lead levels. Only 27.6% had blood lead levels substantially lower than the universal testing mandated by the Centers for Medicare and Medicaid Services. Physicians overestimated the number of children having blood lead tests, even with adjusting for patient non-compliance. Practices varied sharply in their approach to screening. Of 489 patients without findable lead test results, 139 (28.4%) were attributable to previous screening, 98 (20.0%) to patient failure, 181 (37.0%) to physician failure, 52 (10.6%) to patient + physician failure and 19 (3.9%) were indeterminate. There is need for improvement, standardization and unification of lead screening guidelines. Understanding barriers to blood lead testing is also necessary to develop credible data to promote shifts in public policy regarding lead abatement. Further studies should be done, such as interviews and questionnaires to determine why physicians fail to order blood lead tests, and patients fail to appear for a test that has been ordered.
More Related Videos
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
05:35A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
